Cerveau Technologies, Inc. today announced formation of its Scientific Advisory Board (SAB), comprised of top tier physicians and scientists from around the globe, spanning areas of expertise from chemistry, biology to medicine associated with the assessment and ultimate treatment of neurodegenerative diseases, such as Alzheimer’s Disease.
MK-6240 Users Group Meeting | Webinar #1 by Cerveau Technologies Inc
2020 Virtual Conference with world renowned Leaders and Scientists in the industry!
Rick Hiatt (Cerveau Technologies)
Oskar Hannson (Lund University)
Pedro Rosa-Neto (McGill University)
Keith Johnson (Harvard University)
Kuang Gong (Harvard University)
Christopher Rowe (University of Melbourne)
See the conference here
TORONTO–(BUSINESS WIRE)–Enigma Biomedical Group (EBG) today announced the appointment of Michael Reitermann to their Board of Directors effective December 1, 2019